why choose us

First received: August 03, 2023

Clinical Trial: Azeliragon in MGMT Unmethylated Glioblastoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Glioblastoma

Study Type: INTERVENTIONAL


Official Title: A Phase II Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon in Patients With MGMT Unmethylated Glioblastoma

Brief Summary: This is a phase 2 study to evaluate the safety and preliminary evidence of effectiveness of azeliragon, in combination with radiation therapy, as an initial treatment of a form of glioblastoma.Glioblastoma is a type of brain cancer that grows quickly and can invade and destroy healthy tissue.There's no cure for glioblastoma, which is also known as glioblastoma multiforme.Treatments, including surgery, radiation, and chemotherapy might slow cancer growth and reduce symptoms.New treatments of glioblastoma are…

Read more